US Hepatitis Market 2019-2023: Supplier Shares and Sales Forecasts for 10 Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.  The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals                                                                              
     - Commercial/Private Labs
     - Blood Banks
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other Technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative Technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 241 pages and 14 tables